SCHEMBL22019971

SCHEMBL22019971

CCc1csc(S(=N)(N)=O)c1

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA2 P00918 19/20 0.37
LOXL2 Q9Y4K0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21963164 0.85 CA2 (0.50) CA2
SCHEMBL22019975 0.83 CA2 (0.32) CA2
SCHEMBL21963394 0.77 CA2 (0.33) CA2LOXL2
SCHEMBL23569830 0.75 CA2 (0.42) CA2
SCHEMBL22019973 0.74 CA2 (0.32) CA2
SCHEMBL23569834 0.72 CA2 (0.36) CA2
SCHEMBL23569835 0.71 CA2 (0.39) CA2
SCHEMBL21963410 0.71 CA2 (0.36) CA2
SCHEMBL22011768 0.70 CA2 (0.36) CA2
SCHEMBL20692097 0.70 CA2 (0.43) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed